Oxford Biodynamics ROE 2024

Oxford Biodynamics Aktienanalyse

What does Oxford Biodynamics do?

Oxford Biodynamics PLC is a company specialized in the development and application of epigenetic technologies. It was founded in 2007 in Oxford, United Kingdom and has since then had an impressive track record in researching and developing new methods for the detection and treatment of diseases. The business model of Oxford Biodynamics is to utilize its proprietary technology platform, EpiSwitch®, to offer validation and screening services to customers in the pharmaceutical and biotech industries. Oxford Biodynamics' technology platform utilizes epigenetic information to diagnose and predict diseases. The company also uses its technology to identify biomarkers that provide unique insights into the biological processes associated with specific diseases. Oxford Biodynamics operates in three main areas: diagnostics, research and development, and nanoparticle technology. In the diagnostics field, the company offers blood tests for early detection of breast cancer and other types of cancer. The tests utilize a combination of epigenetic signatures and artificial intelligence to deliver results. Oxford Biodynamics is also developing a test to aid in the diagnosis of neurodegenerative diseases such as Parkinson's and Alzheimer's. In the research and development field, Oxford Biodynamics collaborates closely with pharmaceutical and biotech companies to identify epigenetic signatures specific to certain diseases. The company has already worked with major pharmaceutical companies to test the effectiveness of drugs in treating lung cancer and breast cancer. Oxford Biodynamics has also started a collaboration with the John Radcliffe Hospital in Oxford to develop new epigenetics-based methods for predicting premature births. In the nanoparticle technology field, the company utilizes its expertise in epigenetics to develop new technologies that enhance drug delivery and increase the therapeutic effects of medications. The company is currently developing a new type of nanoparticles specifically designed to target cancer cells. These nanoparticles are able to selectively concentrate on cancer cells and directly enter the targeted tissue, minimizing unwanted side effects and maximizing effectiveness. Overall, Oxford Biodynamics is a leading company in epigenetics research and technology development. The company has already made significant advancements in developing new diagnostic and therapeutic methods for various diseases and is constantly working to improve its technologies and expand its product range. The future of the company looks very promising as epigenetics becomes increasingly important in medical research and diagnostics, and Oxford Biodynamics is one of the leading companies in this field. Oxford Biodynamics ist eines der beliebtesten Unternehmen auf Eulerpool.com.

ROE Details

Decoding Oxford Biodynamics's Return on Equity (ROE)

Oxford Biodynamics's Return on Equity (ROE) is a fundamental metric evaluating the company's profitability relative to its equity. Calculated by dividing net income by shareholder's equity, ROE illustrates how effectively the company is generating profits from shareholders’ investments. A higher ROE represents enhanced efficiency and profitability.

Year-to-Year Comparison

Analyzing Oxford Biodynamics's ROE on a yearly basis aids in tracking its profitability trends and financial performance. An increasing ROE suggests enhanced profitability and value generation for shareholders, whereas a declining ROE may indicate issues in profit generation or equity management.

Impact on Investments

Oxford Biodynamics's ROE is instrumental for investors assessing the company's profitability, efficiency, and investment attractiveness. A robust ROE indicates the firm’s adeptness at converting equity investments into profits, thereby enhancing its appeal to potential and current investors.

Interpreting ROE Fluctuations

Changes in Oxford Biodynamics’s ROE can emanate from variations in net income, equity capital, or both. These fluctuations are scrutinized to evaluate management’s effectiveness, financial strategies, and the inherent risks and opportunities, aiding investors in making informed decisions.

Frequently Asked Questions about Oxford Biodynamics Stock

What is the ROE (Return on Equity) of Oxford Biodynamics this year?

The ROE of Oxford Biodynamics this year is -1.79 undefined.

How has the Return on Equity (ROE) of Oxford Biodynamics developed compared to the previous year?

The ROE of Oxford Biodynamics has increased by -31.04% decreased compared to the previous year.

What impact does a high ROE (Return on Equity) have on investors of Oxford Biodynamics?

A high ROE indicates that Oxford Biodynamics generates good returns on capital and is successful in monetizing its investments. This is a positive indicator for investors.

What impact does a low ROE (Return on Equity) have on investors of Oxford Biodynamics?

A low ROE can indicate that Oxford Biodynamics is having difficulties monetizing its investments successfully and can be a negative signal for investors.

How does a change in the ROE (Return on Equity) of Oxford Biodynamics affect the company?

A change in ROE (Return on Equity) of Oxford Biodynamics can be an indicator of the financial performance of the company and demonstrate how successful the company is compared to other companies in the same industry.

How to calculate the ROE (Return on Equity) of Oxford Biodynamics?

The ROE (Return on Equity) is calculated by dividing the company's profit by the total equity. The formula is: ROE = Profit / Total equity.

Which factors influence the ROE (Return on Equity) of Oxford Biodynamics?

Some factors that can influence Oxford Biodynamics's Return on Equity (ROE) include the efficiency in using equity, the profitability of the company, and the financing structure.

What strategic measures can take to improve the ROE (Return on Equity)?

To improve the Return on Equity (ROE), can take measures such as cost savings, increasing revenue, improving efficiency in the use of equity, and making changes in the financing structure. It is important for the company to conduct a thorough review of its financial situation to determine the best strategic actions to improve ROE.

How much dividend does Oxford Biodynamics pay?

Over the past 12 months, Oxford Biodynamics paid a dividend of . This corresponds to a dividend yield of about . For the coming 12 months, Oxford Biodynamics is expected to pay a dividend of 0 GBP.

What is the dividend yield of Oxford Biodynamics?

The current dividend yield of Oxford Biodynamics is .

When does Oxford Biodynamics pay dividends?

Oxford Biodynamics pays a quarterly dividend. This is distributed in the months of .

How secure is the dividend of Oxford Biodynamics?

Oxford Biodynamics paid dividends every year for the past 0 years.

What is the dividend of Oxford Biodynamics?

For the upcoming 12 months, dividends amounting to 0 GBP are expected. This corresponds to a dividend yield of 0 %.

In which sector is Oxford Biodynamics located?

Oxford Biodynamics is assigned to the 'Health' sector.

Wann musste ich die Aktien von Oxford Biodynamics kaufen, um die vorherige Dividende zu erhalten?

To receive the latest dividend of Oxford Biodynamics from 6/27/2024 amounting to 0 GBP, you needed to have the stock in your portfolio before the ex-date on 6/27/2024.

When did Oxford Biodynamics pay the last dividend?

The last dividend was paid out on 6/27/2024.

What was the dividend of Oxford Biodynamics in the year 2023?

In the year 2023, Oxford Biodynamics distributed 0 GBP as dividends.

In which currency does Oxford Biodynamics pay out the dividend?

The dividends of Oxford Biodynamics are distributed in GBP.